Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Radiance Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Radiance Therapeutics

Radiance Therapeutics

Series A

Radiance Therapeutics, a US biotech firm, specializes in novel anti-metabolite therapy for glaucoma surgery.

HQ
Tucson, AZ, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Radiance Therapeutics, founded in the United States, is a biotechnology company dedicated to advancing healthcare through innovative anti-metabolite therapies. The company's core mission is to improve outcomes for patients undergoing glaucoma drainage surgery by leveraging clinically demonstrated treatments. Radiance Therapeutics aims to address unmet medical needs in ophthalmology, focusing specifically on enhancing surgical success rates and patient recovery.

Notable figures associated with Radiance Therapeutics include leading experts in biotechnology and ophthalmology, though specific names are not publicly detailed. The company has garnered attention for its pioneering approach to glaucoma treatment, contributing significantly to the field with its novel therapies. Radiance Therapeutics' impact is seen in its potential to transform glaucoma surgery, offering new hope for patients and setting new standards in ophthalmic care.

Radiance Therapeutics - Similar Companies

XRad Therapeutics logo

XRad Therapeutics

Perfuse Therapeutics logo

Perfuse Therapeutics

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

Raze Therapeutics logo

Raze Therapeutics

razetx.com

Radimmune Therapeutics logo

Radimmune Therapeutics

Rainier Therapeutics logo

Rainier Therapeutics

TherOptix logo

TherOptix

Imagen Biotech logo

Imagen Biotech

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Faze Medicines logo

Faze Medicines

fazemed.com

RadioRx logo

RadioRx

radiorx.com

Adtech Pharma logo

Adtech Pharma

adtechpharma.com

Drive Therapeutics logo

Drive Therapeutics

Visiox logo

Visiox

visioxpharma.com

Rekindle Therapeutics logo

Rekindle Therapeutics

Radiance Therapeutics - Quick Facts

Who are Radiance Therapeutics' competitors?

Companies similar to Radiance Therapeutics include XRad Therapeutics, Perfuse Therapeutics, Radionetics Oncology and Raze Therapeutics.

When was Radiance Therapeutics founded?

Radiance Therapeutics was founded in 2018.

Where is Radiance Therapeutics' headquarters located?

Radiance Therapeutics' headquarters is located in Tucson, AZ, US.

When was Radiance Therapeutics' last funding round?

Radiance Therapeutics' most recent funding round was for $6.2M (USD) in January 2019.

How much has Radiance Therapeutics raised to-date?

As of Jan 9, 2019, Radiance Therapeutics has raised a total of $7.2M (USD).

How many employees does Radiance Therapeutics have?

Radiance Therapeutics has 30 employees as of Feb 5, 2024.

Radiance Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Anti-Metabolite Therapy
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified